Ketosis-prone Diabetes presenting with Acute Esophageal Necrosis or “Black Esophagus”: An Intriguing New Clinical Association.

IF 2 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Riccardo Maria Pollis, Damiano Furlanetto, Elena Pagin, Carla Scaroni, Mattia Barbot, Giacomo Voltan
{"title":"Ketosis-prone Diabetes presenting with Acute Esophageal Necrosis or “Black Esophagus”: An Intriguing New Clinical Association.","authors":"Riccardo Maria Pollis, Damiano Furlanetto, Elena Pagin, Carla Scaroni, Mattia Barbot, Giacomo Voltan","doi":"10.2174/0118715303279019231127065331","DOIUrl":null,"url":null,"abstract":"Background:: Ketosis-prone diabetes (KPD) is an intermediate subtype of diabetes mellitus, usually affecting Afro-American adults, presenting with diabetic ketoacidosis (DKA), without the classic phenotype of autoimmune type 1 diabetes. Patients require insulin therapy at onset for the acute decompensation, then usually remain insulin-free for prolonged periods with diet alone or with other antidiabetic drugs. DKA can be rarely complicated by upper gastrointestinal bleeding and mucosal necrosis, a severe complication named acute esophageal necrosis (AEN) burdened by high mortality. The association of KPD presenting with DKA complicated by AEN is here reported for the first time, to the knowledge of the authors, in the medical literature. Case Presentation:: Here we report an interesting case of middle-aged African woman, newly diagnosed with KPD, presenting with DKA hematemesis. The patient was first treated at Intensive Care Unit for the ketoacidosis with intravenous fluids combined with continuous insulin infusion, and then switched to subcutaneous regimen. At the same time, esophagogastroduodenoscopy (EGD) was performed to diagnose acute esophageal necrosis, which was promptly managed with proton pump inhibitors infusion, fasting, and parenteral nutrition. After the correct clinical evaluation, the patient was switched to oral antidiabetic and basal insulin at discharge and an EGD follow-up was scheduled. Conclusions:: KPD remains an under-recognized and under-diagnosed type of diabetes which can present as DKA. Since DKA could be a possible trigger of AEN, a rare but potentially lifethreatening condition, that clinicians should be aware of, in patients presenting with upper gastrointestinal bleeding and ketoacidosis. The prompt management and classification of DKA, combined with the EGD execution for early AEN diagnosis and follow-up, is essential.","PeriodicalId":11614,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":"68 1","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine, metabolic & immune disorders drug targets","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0118715303279019231127065331","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background:: Ketosis-prone diabetes (KPD) is an intermediate subtype of diabetes mellitus, usually affecting Afro-American adults, presenting with diabetic ketoacidosis (DKA), without the classic phenotype of autoimmune type 1 diabetes. Patients require insulin therapy at onset for the acute decompensation, then usually remain insulin-free for prolonged periods with diet alone or with other antidiabetic drugs. DKA can be rarely complicated by upper gastrointestinal bleeding and mucosal necrosis, a severe complication named acute esophageal necrosis (AEN) burdened by high mortality. The association of KPD presenting with DKA complicated by AEN is here reported for the first time, to the knowledge of the authors, in the medical literature. Case Presentation:: Here we report an interesting case of middle-aged African woman, newly diagnosed with KPD, presenting with DKA hematemesis. The patient was first treated at Intensive Care Unit for the ketoacidosis with intravenous fluids combined with continuous insulin infusion, and then switched to subcutaneous regimen. At the same time, esophagogastroduodenoscopy (EGD) was performed to diagnose acute esophageal necrosis, which was promptly managed with proton pump inhibitors infusion, fasting, and parenteral nutrition. After the correct clinical evaluation, the patient was switched to oral antidiabetic and basal insulin at discharge and an EGD follow-up was scheduled. Conclusions:: KPD remains an under-recognized and under-diagnosed type of diabetes which can present as DKA. Since DKA could be a possible trigger of AEN, a rare but potentially lifethreatening condition, that clinicians should be aware of, in patients presenting with upper gastrointestinal bleeding and ketoacidosis. The prompt management and classification of DKA, combined with the EGD execution for early AEN diagnosis and follow-up, is essential.
易患酮病的糖尿病患者出现急性食管坏死或 "黑色食管":引人入胜的新临床关联。
背景酮症酸中毒型糖尿病(KPD)是糖尿病的中间亚型,通常影响非裔美国成年人,表现为糖尿病酮症酸中毒(DKA),没有自身免疫性 1 型糖尿病的典型表型。患者在发病时需要使用胰岛素治疗急性失代偿,然后通常只通过饮食或其他抗糖尿病药物长期维持无胰岛素状态。DKA 在极少数情况下会并发上消化道出血和粘膜坏死,这种严重的并发症被命名为急性食管坏死(AEN),死亡率很高。据作者所知,KPD 合并 DKA 并发 AEN 的病例在医学文献中尚属首次报道。病例介绍我们在此报告了一例有趣的病例,患者为非洲裔中年女性,新诊断为 KPD,并伴有 DKA 吐血。患者首先在重症监护室接受了酮症酸中毒治疗,静脉输液并持续输注胰岛素,随后转为皮下注射治疗。同时,进行了食管胃十二指肠镜检查(EGD),诊断为急性食管坏死,并及时输注质子泵抑制剂、禁食和肠外营养。经过正确的临床评估后,患者出院时改用口服抗糖尿病药物和基础胰岛素,并安排了胃肠镜检查随访。结论KPD 仍是一种未被充分认识和诊断的糖尿病类型,可表现为 DKA。由于 DKA 可能是 AEN 的诱发因素,临床医生应注意出现上消化道出血和酮症酸中毒的患者,这是一种罕见但可能危及生命的疾病。对 DKA 进行及时处理和分类,并结合胃肠道造影术进行早期 AEN 诊断和随访是至关重要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Endocrine, metabolic & immune disorders drug targets
Endocrine, metabolic & immune disorders drug targets ENDOCRINOLOGY & METABOLISMIMMUNOLOGY-IMMUNOLOGY
CiteScore
4.60
自引率
5.30%
发文量
217
期刊介绍: Aims & Scope This journal is devoted to timely reviews and original articles of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbioma composition are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信